Zobrazeno 1 - 10
of 288
pro vyhledávání: '"Isoniazid/pharmacology"'
Autor:
Katharina Kranzer, Marc Lipman, Ross J Harris, Nikolayevskyy, Ju Sang Kim, Obach D, Zhao H, Hollie-Ann Hatherell, Helen R. Stagg, Ibrahim Abubakar, Tsuchiya N
Publikováno v:
Thorax
Stagg, H R, Harris, R J, Hatherell, H-A, Obach, D, Zhao, H, Tsuchiya, N, Kranzer, K, Nikolayevskyy, V, Kim, J, Lipman, M C & Abubakar, I 2016, ' What are the most efficacious treatment regimens for isoniazid-resistant tuberculosis? A systematic review and network meta-analysis ', Thorax, vol. 71, no. 10, pp. 940-9 . https://doi.org/10.1136/thoraxjnl-2015-208262
Stagg, H R, Harris, R J, Hatherell, H-A, Obach, D, Zhao, H, Tsuchiya, N, Kranzer, K, Nikolayevskyy, V, Kim, J, Lipman, M C & Abubakar, I 2016, ' What are the most efficacious treatment regimens for isoniazid-resistant tuberculosis? A systematic review and network meta-analysis ', Thorax, vol. 71, no. 10, pp. 940-9 . https://doi.org/10.1136/thoraxjnl-2015-208262
INTRODUCTION: Consensus on the best treatment regimens for patients with isoniazid-resistant TB is limited; global treatment guidelines differ. We undertook a systematic review and meta-analysis using mixed-treatment comparisons methodology to provid
Autor:
Thuong Thi Vu, Son Thai Nguyen, Thanh Hoa Thi Tran, Anh Duc Dang, Huy Quang Nguyen, Hung Van Nguyen, Ngoc-Lan Nguyen, Nhung Viet Nguyen, Anne-Laure Bañuls, Van Anh Thi Nguyen, Lucie Contamin
Publikováno v:
Infection, Genetics and Evolution
Infection, Genetics and Evolution, Elsevier, 2017, 50, pp.55-61. ⟨10.1016/j.meegid.2017.02.012⟩
Infection, Genetics and Evolution, Elsevier, 2017, 50, pp.55-61. ⟨10.1016/j.meegid.2017.02.012⟩
International audience; In Vietnam, a country with high tuberculosis (137/100.000 population) and multidrug-resistant (MDR)-TB burdens (7.8/100.000 population), little is known about the molecular signatures of drug resistance in general and more par
Publikováno v:
The American journal of tropical medicine and hygiene
Drug susceptibility testing using molecular techniques can enhance the identification of drug-resistant Mycobacterium tuberculosis. Two multiplex real-time polymerase chain reaction (qPCR) assays were developed to detect the most common resistance-as
Autor:
Mitzi Rodriguez, Dunia Faulx, Luz Caviedes, Chris Crudder, David Moore, Melissa Valdez, Jon S. Friedland, Edith Castillo, Jorge Coronel, Robert H. Gilman, Laura Martin, Louis Grandjean, Mutsumi Metzler
Publikováno v:
PLoS ONE, Vol 9, Iss 9, p e107258 (2014)
PLoS ONE
PLoS ONE
BACKGROUND: Even though the WHO-endorsed, non-commercial MODS assay offers rapid, reliable TB liquid culture and phenotypic drug susceptibility testing (DST) at lower cost than any other diagnostic, uptake has been patchy. In part this reflects mispe
Autor:
Lukas, Fenner, Matthias, Egger, Thomas, Bodmer, Ekkehardt, Altpeter, Marcel, Zwahlen, Katia, Jaton, Gaby E, Pfyffer, Sonia, Borrell, Olivier, Dubuis, Thomas, Bruderer, Hans H, Siegrist, Hansjakob, Furrer, Alexandra, Calmy, Jan, Fehr, Jesica Mazza, Stalder, Béatrice, Ninet, Erik C, Böttger, Sebastien, Gagneux, S, Yerly
Publikováno v:
Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy, Vol. 56, No 6 (2012) pp. 3047-53
Antimicrobial agents and chemotherapy
Antimicrobial Agents and Chemotherapy, Vol. 56, No 6 (2012) pp. 3047-53
Antimicrobial agents and chemotherapy
Bacterial factors may contribute to the global emergence and spread of drug-resistant tuberculosis (TB). Only a few studies have reported on the interactions between different bacterial factors. We studied drug-resistant Mycobacterium tuberculosis is
We have developed a high-resolution melting (HRM) assay to scan for mutations in the rpoB, inhA, ahpC, and katG genes and/or promoter regions for the detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis. For assay development,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1bb7283002f6b96ab22ac3773deaf8a
http://hdl.handle.net/10722/125140
http://hdl.handle.net/10722/125140
Autor:
Karamanakos, P. N., Trafalis, D. T., Geromichalos, G. D., Pappas, P., Harkitis, P., Konstandi, M., Marselos, M.
Increased activity of CYP2E1 has been associated with increased risk of chemically-mediated cancers, through enhanced activation of a variety of procarcinogens. In this context, inhibition of CYP2E1 is potentially of significance in xenobiotic toxici
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10561::41ce23ebfc62f15993501ed7d88002db
http://olympias.lib.uoi.gr/jspui/handle/123456789/20748
http://olympias.lib.uoi.gr/jspui/handle/123456789/20748
Autor:
Richard Y.T. Kao, Kwok-Yung Yuen, Wing-Hong Seto, Pak-Leung Ho, Tai Hing Lam, Wai Lok Woo, Wing-Cheong Yam, E. T. Y. Leung
Publikováno v:
Antimicrobial agents and chemotherapy. 50(3)
Multiplex allele-specific PCRs detecting katG codon 315 and mabA (bp -15) mutations could specifically identify 77.5% of isoniazid-resistant Mycobacterium tuberculosis strains in the South China region. One clinical isolate harboring InhA Ile194Thr w
Treatment of NMRI mice with isoniazid (INH; 25 mg/kg) intraperitoneally induced significant protection when it was injected before or after a lethal intravenous challenge with endotoxin. The INH preparation used was not contaminated with endotoxin. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc08bcc18f1ecf7be47bff2c15c98f6b
https://epub.uni-regensburg.de/21166/
https://epub.uni-regensburg.de/21166/
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.